910575-54-1

Basic information

• Product Name: 2-benzyloxy-5-bromo-1-methoxy-3-methyl-benzene
• Synonyms: 2-benzyloxy-5-bromo-1-methoxy-3-methyl-benzene
• CAS NO: 910575-54-1
• Molecular Weight: 307.187
• Mol File: 910575-54-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-benzyloxy-5-bromo-1-methoxy-3-methyl-benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 2-benzyloxy-5-bromo-1-methoxy-3-methyl-benzene(910575-54-1)
• EPA Substance Registry System: 2-benzyloxy-5-bromo-1-methoxy-3-methyl-benzene(910575-54-1)

Safety Data

• Hazardous Substances Data: 910575-54-1(Hazardous Substances Data)

Upstream product

• 100-39-0 benzyl bromide 
• 86232-54-4 4-bromo-2-methoxy-6-methylphenol 
• 2896-67-5 2-methyl-6-methoxyphenol 

Downstream Products

• 910575-55-2 4-benzyloxy-3-methoxy-5-methyl-benzaldehyde 

Relevant articles and documents

Selected Cgrp-Antagonists, Processes for Preparing Them and Their Use as Pharmaceutical Compositions

The invention relates to CGRP-antagonists of general formula (I), wherein R1, R2, R3, R4 and R5 are defined in claim 1, to the tautomers, isomers, diastereomers, enantiomers, hydrates, mixtures salts and salt hydrates thereof, in particular to 10 salts thereof, which are physiologically compatible with acids or inorganic or organic bases and to compounds of general formula (I), wherein one or several hydrogen atoms are substituted by deuterium. Drugs containing said compounds, the use thereof and a method for the production thereof are also disclosed.

CGRP ANTAGONISTS, METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE AS MEDICAMENTS

The invention relates to CGRP antagonists of general formula (I) in which: R1, R2, R3, R4 and X are defined as in Claim 1, to their tautomers, isomers, diastereomers, enantiomers, hydrates, mixtures and salts as well as the hydrates of the salts, in particular, their physiologically compatible salts with inorganic or organic acids and bases, and those compounds of general formula (I) in which one or more hydrogen atoms are replaced by deuterium. The invention also relates to medicaments containing these compounds, the use thereof, and to methods for producing them.